XML 23 R8.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net loss $ (102,400) $ (126,036)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation 61,057 60,319
Equity Securities, FV-NI, Gain (Loss) (764) (1,115)
Deferred tax expense (benefit) (1,013) 2,225
Stock-based compensation 110,401 116,925
Gain on Settlement of Convertible Notes 0 (10,254)
Amortization of acquired intangible assets 48,287 46,622
Impairment of long-lived and indefinite-lived assets 6,251 12,598
Gain (Loss) On Contingent Consideration From Disposition Of Asset 0 (3,532)
Remeasurement of contingent consideration liabilities 13,196 (7,636)
Non-cash lease expense 13,483 14,042
Other Noncash Income (Expense) 5,994 (2,667)
Changes in assets and liabilities:    
Accounts receivable, net (103,086) (60,901)
Inventory, net (9,069) 96
Increase (Decrease) in Operating Lease Liability (13,841) (12,957)
Accounts payable and accrued liabilities 98,048 (17,865)
Other assets (4,787) (2,719)
Other liabilities (13,033) 9,941
Net cash provided by operating activities 119,826 24,754
Cash flows from investing activities:    
Purchases of marketable securities (93,796) (324,372)
Maturities and sales of marketable securities 330,429 80,335
Purchases of property, plant and equipment (73,516) (73,515)
Other investing activities 145 (205)
Net cash provided by (used in) investing activities 190,458 (318,567)
Cash flows from financing activities:    
Repayments of Convertible Debt (249,172) 0
Payment, Tax Withholding, Share-Based Payment Arrangement (129) (1,365)
Other financing activities (8,417) (13,186)
Net cash provided by (used in) financing activities (260,685) 221,601
Reconciliation of cash, cash equivalents and restricted cash:    
Cash and cash equivalents 657,099 530,180
Restricted cash — included in other long-term assets, net 0 5,837
Total cash, cash equivalents and restricted cash 657,099 536,017
Supplemental disclosure of cash flow information:    
Interest paid 15,635 11,971
Supplemental disclosure of non-cash investing and financing activities    
Issuance of common stock to fund the Company's 401(k) match 43,943 40,550
Property, plant and equipment acquired but not paid 14,124 12,442
Cash, cash equivalents and restricted cash, end of period 657,099 536,017
Cash, cash equivalents and restricted cash, beginning of period 606,636 609,675
Net increase (decrease) in cash, cash equivalents and restricted cash 50,463 (73,658)
Effects of exchange rate changes on cash and cash equivalents 864 (1,446)
Payments to Acquire Other Investments (775) (810)
Proceeds From Contingent Consideration Receivable 27,971 0
Proceeds from Stock Plans 16,033 19,402
Repayments of Accounts Receivable Securitization 0 (50,000)
Proceeds from Convertible Debt 0 266,750
Payment for Contingent Consideration Liability, Financing Activities $ 19,000 $ 0